prof. martin reck on elcc 2017 and what makes it a unique lung cancer conference
Published 7 years ago • 219 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
5:53
martin reck:
-
3:52
important topics at esmo 2017
-
0:55
the potential of targeted and immune therapies in sclc
-
1:23
targeted therapies for advanced nsclc
-
22:52
metastatic lung cancer | 2022 oneoncology conference
-
5:10
the spectrum of outcomes for small cell lung cancer
-
7:23
is keto an effective cancer fighting diet?
-
3:01
virtual oncology meetings
-
1:05
dr. reck on the rationale of the impower150 trial in nsclc
-
27:25
icaho 2017 - dr. renato martins
-
1:00
the genetic landscape of lung cancer
-
7:31
elcc 2010: prof peter harper discusses the treatment of lung cancer
-
1:46
dr. martin reck on docetaxel/ramucirumab in nsclc
-
0:56
biomarkers are revolutionizing the treatment landscape for nsclc
-
26:50
icaho 2017 - dr. wallace akerley
-
2:09
dr. reck on the impower150 study
-
0:47
why is european lung cancer conference so important?
-
1:42
immunotherapy at the 10th european lung cancer conference 2016
-
2:53
dr. reck discusses mss of lcss as prognostic and predictive factor for os in squire study
-
40:50
dr jordan curry “the benefits of exercise on lung cancer”
-
4:26
asco 2016 martin reck interview